Abstract:The molecular mediators of cell death and inflammation in Alzheimer's disease (AD) have yet to be fully elucidated. Caspase-8 is a critical regulator of several cell death and inflammatory pathways; however, its role in AD pathogenesis has not yet been examined in detail. In the absence of Caspase-8, mice are embryonic lethal due to excessive RIPK3-dependent necroptosis. Compound RIPK3 and Caspase-8 mutants rescue embryonic lethality, which we leveraged to examine the roles of these pathways in an amyloid beta… Show more
“…However, it is important to note that we have not been able to detect appreciable levels of microglia cell death by TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) staining in the 5xFAD model in our previous studies. 27,35 Therefore, it is more likely that enhanced microglial proliferation contributes to the increase in microglia numbers seen in SHIP-1-deficeint 5xFAD mice.…”
Section: Ship-1 Deletion Increases Microglial Numbers and Mobilizatio...mentioning
IntroductionMutations in INPP5D, which encodes for the SH2‐domain‐containing inositol phosphatase SHIP‐1, have recently been linked to an increased risk of developing late‐onset Alzheimer's disease. While INPP5D expression is almost exclusively restricted to microglia in the brain, little is known regarding how SHIP‐1 affects neurobiology or neurodegenerative disease pathogenesis.MethodsWe generated and investigated 5xFAD Inpp5dfl/flCx3cr1Ert2Cre mice to ascertain the function of microglial SHIP‐1 signaling in response to amyloid beta (Aβ)‐mediated pathology.ResultsSHIP‐1 deletion in microglia led to substantially enhanced recruitment of microglia to Aβ plaques, altered microglial gene expression, and marked improvements in neuronal health. Further, SHIP‐1 loss enhanced microglial plaque containment and Aβ engulfment when compared to microglia from Cre‐negative 5xFAD Inpp5dfl/fl littermate controls.DiscussionThese results define SHIP‐1 as a pivotal regulator of microglial responses during Aβ‐driven neurological disease and suggest that targeting SHIP‐1 may offer a promising strategy to treat Alzheimer's disease.Highlights
Inpp5d deficiency in microglia increases plaque‐associated microglia numbers.
Loss of Inpp5d induces activation and phagocytosis transcriptional pathways.
Plaque encapsulation and engulfment by microglia are enhanced with Inpp5d deletion.
Genetic ablation of Inpp5d protects against plaque‐induced neuronal dystrophy.
“…However, it is important to note that we have not been able to detect appreciable levels of microglia cell death by TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) staining in the 5xFAD model in our previous studies. 27,35 Therefore, it is more likely that enhanced microglial proliferation contributes to the increase in microglia numbers seen in SHIP-1-deficeint 5xFAD mice.…”
Section: Ship-1 Deletion Increases Microglial Numbers and Mobilizatio...mentioning
IntroductionMutations in INPP5D, which encodes for the SH2‐domain‐containing inositol phosphatase SHIP‐1, have recently been linked to an increased risk of developing late‐onset Alzheimer's disease. While INPP5D expression is almost exclusively restricted to microglia in the brain, little is known regarding how SHIP‐1 affects neurobiology or neurodegenerative disease pathogenesis.MethodsWe generated and investigated 5xFAD Inpp5dfl/flCx3cr1Ert2Cre mice to ascertain the function of microglial SHIP‐1 signaling in response to amyloid beta (Aβ)‐mediated pathology.ResultsSHIP‐1 deletion in microglia led to substantially enhanced recruitment of microglia to Aβ plaques, altered microglial gene expression, and marked improvements in neuronal health. Further, SHIP‐1 loss enhanced microglial plaque containment and Aβ engulfment when compared to microglia from Cre‐negative 5xFAD Inpp5dfl/fl littermate controls.DiscussionThese results define SHIP‐1 as a pivotal regulator of microglial responses during Aβ‐driven neurological disease and suggest that targeting SHIP‐1 may offer a promising strategy to treat Alzheimer's disease.Highlights
Inpp5d deficiency in microglia increases plaque‐associated microglia numbers.
Loss of Inpp5d induces activation and phagocytosis transcriptional pathways.
Plaque encapsulation and engulfment by microglia are enhanced with Inpp5d deletion.
Genetic ablation of Inpp5d protects against plaque‐induced neuronal dystrophy.
“…Pycard (PYD and CARD domain containing gene, encoding for adapter protein apoptosis-associated speck-like protein containing a CARD (ASC)) codes for an inflammasome component and is involved in regulation of autophagy. Previous reports demonstrated that released ASC specks can bind to Aβ, enhance its aggregation, and increase its toxicity [ 159 ]. In our study, Pycard turned out to be a unique fingerprint for the RS cortex of female APP/PS1 mice.…”
A variety of Alzheimer’s disease (AD) mouse models has been established and characterized within the last decades. To get an integrative view of the sophisticated etiopathogenesis of AD, whole genome transcriptome studies turned out to be indispensable. Here we carried out microarray data collection based on RNA extracted from the retrosplenial cortex and hippocampus of age-matched, eight months old male and female APP/PS1 AD mice and control animals to perform sex- and brain region specific analysis of transcriptome profiles. The results of our studies reveal novel, detailed insight into differentially expressed signature genes and related fold changes in the individual APP/PS1 subgroups. Gene ontology and Venn analysis unmasked that intersectional, upregulated genes were predominantly involved in, e.g., activation of microglial, astrocytic and neutrophilic cells, innate immune response/immune effector response, neuroinflammation, phagosome/proteasome activation, and synaptic transmission. The number of (intersectional) downregulated genes was substantially less in the different subgroups and related GO categories included, e.g., the synaptic vesicle docking/fusion machinery, synaptic transmission, rRNA processing, ubiquitination, proteasome degradation, histone modification and cellular senescence. Importantly, this is the first study to systematically unravel sex- and brain region-specific transcriptome fingerprints/signature genes in APP/PS1 mice. The latter will be of central relevance in future preclinical and clinical AD related studies, biomarker characterization and personalized medicinal approaches.
“…However, when caspase-8 was inhibited genetically or chemically, the peroxisome (RIPK3–MLKL) could bind to the NLRP3 inflammasome to promote IL-1β activation, which is consistent with other previous studies demonstrating that both pathways are intracellular in origin. These findings indicate that RIPK3-induced inflammation may be driven by factors other than necroptosis and DAMP release [ 72 , 73 ]. …”
Receptor-interacting protein kinase 3 (RIPK3), a member of the receptor-interacting protein kinase (RIPK) family with serine/threonine protein kinase activity, interacts with RIPK1 to generate necrosomes, which trigger caspase-independent programmed necrosis. As a vital component of necrosomes, RIPK3 plays an indispensable role in necroptosis, which is crucial for human life and health. In addition, RIPK3 participates in the pathological process of several infections, aseptic inflammatory diseases, and tumors (including tumor-promoting and -suppressive activities) by regulating autophagy, cell proliferation, and the metabolism and production of chemokines/cytokines. This review summarizes the recent research progress of the regulators of the RIPK3 signaling pathway and discusses the potential role of RIPK3/necroptosis in the aetiopathogenesis of various diseases. An in-depth understanding of the mechanisms and functions of RIPK3 may facilitate the development of novel therapeutic strategies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.